Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia

Oncol Rep. 1999 Mar-Apr;6(2):269-76. doi: 10.3892/or.6.2.269.

Abstract

Our aim was to establish an effective non-surgical treatment for cervical intraepithelial neoplasia (CIN) through inactivation of human papillomavirus (HPV), the major etiological agent for this disease. We show that vidarabine, a DNA polymerase inhibitor, suppressed growth and HPV gene expression in human cervical keratinocytes immortalized by HPV or in cervical cancer cell lines. Expression of HPV-16 E6 and E7 proteins in normal cervical keratinocytes sensitized cells to apoptosis in the presence of podophyllin or vidarabine. We applied vidarabine ointment and/or podophyllin to cervical epithelium in 28 cases of CIN I-II to evaluate the therapeutic effectiveness of these agents. Co-application of vidarabine and podophyllin in six treatments caused regression of lesions cytologically and histologically, and disappearance of HPV-16 or -18 DNA in 17 of 21 (81%) women. Our results suggest that the combination of vidarabine and podophyllin therapy is an effective non-surgical treatment for HPV-positive CIN.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Apoptosis
  • Carcinoma in Situ / drug therapy*
  • Carcinoma in Situ / pathology
  • Carcinoma in Situ / virology
  • Cell Division / drug effects
  • Cells, Cultured
  • Female
  • Gene Expression Regulation, Viral / drug effects
  • Humans
  • Keratinocytes / drug effects
  • Keratinocytes / virology
  • Middle Aged
  • Neoplasm Staging
  • Papillomaviridae / drug effects
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / drug therapy*
  • Papillomavirus Infections / pathology
  • Podophyllin / therapeutic use*
  • Tumor Cells, Cultured
  • Tumor Virus Infections / complications
  • Tumor Virus Infections / drug therapy*
  • Tumor Virus Infections / pathology
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / virology
  • Vidarabine / therapeutic use*

Substances

  • Antineoplastic Agents, Phytogenic
  • Antiviral Agents
  • Podophyllin
  • Vidarabine